| Dr Michael L Mawby, MD | |
|
1115 S Union St, Traverse City, MI 49684-3258 | |
| (231) 935-0550 | |
| (231) 935-0551 |
| Full Name | Dr Michael L Mawby |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 37 Years |
| Location | 1115 S Union St, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720084114 | NPI | - | NPPES |
| 1102802841 | Other | MI | BC/BS OF MI |
| 131101 | Other | MI | UNITED HEALTH CARE |
| 1720084114 | Other | MI | MICHAEL L MAWBY MD |
| 1102802841 | Other | MI | BLUE CARE NETWORK |
| 4324974 | Medicaid | MI | |
| 660003547 | Other | MI | TRICARE/CHAMPUS |
| F60038 | Other | MI | PRIORITY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 4301051186 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Munson Healthcare Cadillac Hospital | Cadillac, MI | Hospital |
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Munson Healthcare Grayling Hospital | Grayling, MI | Hospital |
| Mclaren Northern Michigan | Petoskey, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infusion Associates Pllc | 0840185203 | 27 |
News Archive
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
At the Institut Curie, CNRS and Inserm researchers have shown that cysteamine, which is already used to treat a rare disease called cystinosis, prevents the death of neurons in Huntington's disease. Like Alzheimer's and Parkinson's, Huntington's disease, is characterized by the abnormal death of neurons.
Biologists at Texas A&M University are making strides in understanding biological clock function in several model organisms and translating these studies into broader implications for human health.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.
› Verified 8 days ago
| Entity Name | Infusion Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487622296 PECOS PAC ID: 0840185203 Enrollment ID: O20040322001830 |
News Archive
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
At the Institut Curie, CNRS and Inserm researchers have shown that cysteamine, which is already used to treat a rare disease called cystinosis, prevents the death of neurons in Huntington's disease. Like Alzheimer's and Parkinson's, Huntington's disease, is characterized by the abnormal death of neurons.
Biologists at Texas A&M University are making strides in understanding biological clock function in several model organisms and translating these studies into broader implications for human health.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael L Mawby, MD Po Box 728, Traverse City, MI 49685-0728 Ph: (231) 935-0550 | Dr Michael L Mawby, MD 1115 S Union St, Traverse City, MI 49684-3258 Ph: (231) 935-0550 |
News Archive
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
At the Institut Curie, CNRS and Inserm researchers have shown that cysteamine, which is already used to treat a rare disease called cystinosis, prevents the death of neurons in Huntington's disease. Like Alzheimer's and Parkinson's, Huntington's disease, is characterized by the abnormal death of neurons.
Biologists at Texas A&M University are making strides in understanding biological clock function in several model organisms and translating these studies into broader implications for human health.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.
› Verified 8 days ago
John P Milliken, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 224 Circle Dr, Traverse City, MI 49684 Phone: 231-935-0525 Fax: 231-935-0529 | |
Dr. David R Hendricks, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 E Front St, Traverse City, MI 49684 Phone: 231-941-6670 Fax: 231-941-6675 | |
Dr. Jill Elizabeth Vollbrecht, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5015 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0850 Fax: 231-935-0850 | |
Dr. Katrina Marie Lawrence-wolff, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste A, Traverse City, MI 49684 Phone: 231-935-8330 Fax: 231-935-3437 | |
Steven M. Lamie, M. D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3537 W Front St, Suite I, Traverse City, MI 49684 Phone: 231-935-8950 Fax: 231-935-8868 | |
Anne M Hepner, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Suite 200, Traverse City, MI 49684 Phone: 231-935-5800 Fax: 231-935-5799 | |
Mark V Galan, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 208, Traverse City, MI 49684 Phone: 231-935-5710 Fax: 231-935-9045 |